Arya Sciences Acquisition Corp IV. (ARYD) NASDAQ
$9.77 -0.01 (-0.10%)
Market Cap: $151.09M
As of 05/23/22 04:00 PM EDT. Market closed.
Arya Sciences Acquisition Corp IV. (ARYD) NASDAQ
$9.77 -0.01 (-0.10%)
Market Cap: $151.09M
As of 05/23/22 04:00 PM EDT. Market closed.
ARYA Sciences Acquisition Corp IV is a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on the healthcare industry in the United States and other developed countries. The Company intends to focus on ... read more
ARYA Sciences Acquisition Corp IV is a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses or entities. While the Company may pursue an initial business combination target in any business or industry, it intends to focus on the healthcare industry in the United States and other developed countries. The Company intends to focus on target businesses with valuations of $300 to $500 million or more and that have the potential to be $1 billion or more market capitalization companies. read less
Open in:
Open in:
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Stone Adam Leo | Chief Executive Officer | Mar 02, 2021 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Mar 02, 2021, 04:30 PM |
| ARYA Sciences Holdings IV | 10% Owner | Mar 02, 2021 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Mar 02, 2021, 04:30 PM |
| ALTMAN MICHAEL SETH | Chief Financial Officer | Mar 02, 2021 | Option Exercise | $10.00 | 499,000 | 4,990,000 | 499,000 | Mar 02, 2021, 04:30 PM |
| Owner | Relationship | Date | Value($) |
| Stone Adam Leo | Chief Executive Officer | 03/02/2021 | 4,990,000 |
| ARYA Sciences Holdings IV | 10% Owner | 03/02/2021 | 4,990,000 |
| ALTMAN MICHAEL SETH | Chief Financial Officer | 03/02/2021 | 4,990,000 |
Period of Report: 12/31/2021
10-K/10-Q Filings: View